SHERRY PERRY: Open Payments
NPI 1164778304 · WAYNE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 124 payments from 12 companies in 2025. Trend: 2023 $2,084 · 2024 $1,443 · 2025 $2,044
Food & beverage: $1,933Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $309 |
| Alkermes, Inc. | 16 | $302 |
| Neurocrine BioSciences, Inc. | 16 | $297 |
| Otsuka America Pharmaceutical, Inc. | 18 | $267 |
| E.R. Squibb & Sons, L.L.C. | 11 | $233 |
| Janssen Pharmaceuticals, Inc | 15 | $229 |
| ABBVIE INC. | 21 | $195 |
| Lundbeck LLC | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: INGREZZA, COBENFY, REXULTI, INVEGA SUSTENNA, VRAYLAR, ARISTADA, UZEDY, AUSTEDO XR.
Industry payments across WV — which companies pay providers there.
